Matrix	0	6	B-Gene_or_gene_product
metalloproteinase	7	24	I-Gene_or_gene_product
activity	25	33	O
and	34	37	O
immunohistochemical	38	57	O
profile	58	65	O
of	66	68	O
matrix	69	75	B-Gene_or_gene_product
metalloproteinase	76	93	I-Gene_or_gene_product
-	93	94	I-Gene_or_gene_product
2	94	95	I-Gene_or_gene_product
and	96	99	O
-	100	101	B-Gene_or_gene_product
9	101	102	I-Gene_or_gene_product
and	103	106	O
tissue	107	113	B-Gene_or_gene_product
inhibitor	114	123	I-Gene_or_gene_product
of	124	126	I-Gene_or_gene_product
metalloproteinase	127	144	I-Gene_or_gene_product
-	144	145	I-Gene_or_gene_product
1	145	146	I-Gene_or_gene_product
during	147	153	O
human	154	159	B-Organism
dermal	160	166	B-Multi-tissue_structure
wound	167	172	O
healing	173	180	O
.	180	181	O

Proteolytic	183	194	O
activity	195	203	O
is	204	206	O
required	207	215	O
for	216	219	O
the	220	223	O
turnover	224	232	O
of	233	235	O
the	236	239	O
extracellular	240	253	B-Cellular_component
matrix	254	260	I-Cellular_component
during	261	267	O
wound	268	273	O
healing	274	281	O
.	281	282	O

Matrix	283	289	B-Gene_or_gene_product
metalloproteinases	290	308	I-Gene_or_gene_product
can	309	312	O
collectively	313	325	O
cleave	326	332	O
all	333	336	O
components	337	347	O
of	348	350	O
the	351	354	O
extracellular	355	368	B-Cellular_component
matrix	369	375	I-Cellular_component
,	375	376	O
with	377	381	O
the	382	385	O
endogenous	386	396	O
tissue	397	403	B-Gene_or_gene_product
inhibitor	404	413	I-Gene_or_gene_product
of	414	416	I-Gene_or_gene_product
metalloproteinase	417	434	I-Gene_or_gene_product
-	434	435	I-Gene_or_gene_product
1	435	436	I-Gene_or_gene_product
regulating	437	447	O
their	448	453	O
activity	454	462	O
.	462	463	O

Breast	464	470	B-Tissue
tissue	471	477	I-Tissue
taken	478	483	O
at	484	486	O
varying	487	494	O
postoperative	495	508	O
times	509	514	O
(	515	516	O
n	516	517	O
=	517	518	O
92	519	521	O
)	521	522	O
or	523	525	O
during	526	532	O
surgery	533	540	O
(	541	542	O
controls	542	550	O
,	550	551	O
n	552	553	O
=	553	554	O
17	555	557	O
)	557	558	O
,	558	559	O
was	560	563	O
used	564	568	O
to	569	571	O
investigate	572	583	O
the	584	587	O
temporal	588	596	O
and	597	600	O
spatial	601	608	O
activity	609	617	O
of	618	620	O
matrix	621	627	B-Gene_or_gene_product
metalloproteinase	628	645	I-Gene_or_gene_product
-	645	646	I-Gene_or_gene_product
2	646	647	I-Gene_or_gene_product
and	648	651	O
-	652	653	B-Gene_or_gene_product
9	653	654	I-Gene_or_gene_product
and	655	658	O
tissue	659	665	B-Gene_or_gene_product
inhibitor	666	675	I-Gene_or_gene_product
of	676	678	I-Gene_or_gene_product
metalloproteinase	679	696	I-Gene_or_gene_product
-	696	697	I-Gene_or_gene_product
1	697	698	I-Gene_or_gene_product
during	699	705	O
human	706	711	B-Organism
wound	712	717	O
healing	718	725	O
.	725	726	O

Matrix	727	733	B-Gene_or_gene_product
metalloproteinase	734	751	I-Gene_or_gene_product
activity	752	760	O
,	760	761	O
determined	762	772	O
using	773	778	O
a	779	780	O
quenched	781	789	O
fluorescence	790	802	O
substrate	803	812	O
assay	813	818	O
,	818	819	O
increased	820	829	O
during	830	836	O
early	837	842	O
healing	843	850	O
(	851	852	O
3	852	853	O
-	853	854	O
8	854	855	O
weeks	856	861	O
)	861	862	O
compared	863	871	O
to	872	874	O
controls	875	883	O
,	883	884	O
and	885	888	O
then	889	893	O
decreased	894	903	O
between	904	911	O
24	912	914	O
and	915	918	O
36	919	921	O
weeks	922	927	O
after	928	933	O
surgery	934	941	O
(	942	943	O
p	943	944	O
less	946	950	O
than	951	955	O
0	957	958	O
.	958	959	O
05	959	961	O
until	962	967	O
24	968	970	O
weeks	971	976	O
,	976	977	O
Mann	978	982	O
-	982	983	O
Whitney	983	990	O
U	991	992	O
-	992	993	O
test	993	997	O
)	997	998	O
.	998	999	O

Immunohistochemistry	1000	1020	O
scores	1021	1027	O
for	1028	1031	O
matrix	1032	1038	B-Gene_or_gene_product
metalloproteinase	1039	1056	I-Gene_or_gene_product
-	1056	1057	I-Gene_or_gene_product
9	1057	1058	I-Gene_or_gene_product
expression	1059	1069	O
were	1070	1074	O
significantly	1075	1088	O
elevated	1089	1097	O
compared	1098	1106	O
to	1107	1109	O
controls	1110	1118	O
in	1119	1121	O
scar	1122	1126	O
endothelial	1127	1138	B-Cell
cells	1139	1144	I-Cell
and	1145	1148	O
fibroblasts	1149	1160	B-Cell
from	1161	1165	O
2	1166	1167	O
until	1168	1173	O
12	1174	1176	O
and	1177	1180	O
20	1181	1183	O
weeks	1184	1189	O
,	1189	1190	O
respectively	1191	1203	O
.	1203	1204	O

Matrix	1205	1211	B-Gene_or_gene_product
metalloproteinase	1212	1229	I-Gene_or_gene_product
-	1229	1230	I-Gene_or_gene_product
2	1230	1231	I-Gene_or_gene_product
staining	1232	1240	O
was	1241	1244	O
observed	1245	1253	O
exclusively	1254	1265	O
in	1266	1268	O
fibroblasts	1269	1280	B-Cell
,	1280	1281	O
reaching	1282	1290	O
maximum	1291	1298	O
levels	1299	1305	O
8	1306	1307	O
-	1307	1308	O
12	1308	1310	O
weeks	1311	1316	O
after	1317	1322	O
surgery	1323	1330	O
,	1330	1331	O
decreasing	1332	1342	O
by	1343	1345	O
1	1346	1347	O
.	1347	1348	O
5	1348	1349	O
years	1350	1355	O
but	1356	1359	O
remaining	1360	1369	O
significantly	1370	1383	O
increased	1384	1393	O
.	1393	1394	O

Tissue	1395	1401	B-Gene_or_gene_product
inhibitor	1402	1411	I-Gene_or_gene_product
of	1412	1414	I-Gene_or_gene_product
metalloproteinase	1415	1432	I-Gene_or_gene_product
-	1432	1433	I-Gene_or_gene_product
1	1433	1434	I-Gene_or_gene_product
staining	1435	1443	O
was	1444	1447	O
relatively	1448	1458	O
sparse	1459	1465	O
but	1466	1469	O
was	1470	1473	O
significantly	1474	1487	O
increased	1488	1497	O
until	1498	1503	O
8	1504	1505	O
weeks	1506	1511	O
after	1512	1517	O
surgery	1518	1525	O
.	1525	1526	O

These	1527	1532	O
results	1533	1540	O
show	1541	1545	O
that	1546	1550	O
matrix	1551	1557	B-Gene_or_gene_product
metalloproteinases	1558	1576	I-Gene_or_gene_product
are	1577	1580	O
present	1581	1588	O
at	1589	1591	O
elevated	1592	1600	O
levels	1601	1607	O
during	1608	1614	O
early	1615	1620	O
wound	1621	1626	B-Pathological_formation
healing	1627	1634	O
,	1634	1635	O
when	1636	1640	O
angiogenesis	1641	1653	O
occurs	1654	1660	O
,	1660	1661	O
and	1662	1665	O
suggest	1666	1673	O
that	1674	1678	O
matrix	1679	1685	B-Gene_or_gene_product
metalloproteinase	1686	1703	I-Gene_or_gene_product
-	1703	1704	I-Gene_or_gene_product
9	1704	1705	I-Gene_or_gene_product
may	1706	1709	O
play	1710	1714	O
a	1715	1716	O
significant	1717	1728	O
role	1729	1733	O
.	1733	1734	O

The	1735	1738	O
later	1739	1744	O
expression	1745	1755	O
of	1756	1758	O
matrix	1759	1765	B-Gene_or_gene_product
metalloproteinase	1766	1783	I-Gene_or_gene_product
-	1783	1784	I-Gene_or_gene_product
2	1784	1785	I-Gene_or_gene_product
and	1786	1789	O
-	1790	1791	B-Gene_or_gene_product
9	1791	1792	I-Gene_or_gene_product
in	1793	1795	O
fibroblasts	1796	1807	B-Cell
suggests	1808	1816	O
a	1817	1818	O
role	1819	1823	O
in	1824	1826	O
extracellular	1827	1840	B-Cellular_component
matrix	1841	1847	I-Cellular_component
remodeling	1848	1858	O
.	1858	1859	O

